This piece is a purely analytical take on the so-called “poison pill” found in First Gen’s recent transactions, aimed at helping the investing public understand how such structures work and how they can affect shareholder value, governance, and risk allocation. By laying open the legal architecture and the economic implications—including potential value impairment running into billions of pesos for institutional investors—Vantage Point argues that this specific application appears to penalize leadership change rather than protect the company itself.

The analysis, which does not pick sides among the factions involved, provides detailed explanation (in financially precise terms) of how the mechanism works and why markets might consider it a risk, rather than a safeguard, to governance.

I have seen enough deal structures over the years to spot when something is designed to protect value—and when it’s designed to protect control. The difference is not semantic. It is economic. 

In the case of First Gen Corporation’s so-called “poison pill,” the structure, as disclosed, does not resemble a conventional defense mechanism. It is akin to a conditional penalty for governance change—one that seems to make it financially costly to everyone else to remove someone. (READ: How to make yourself very expensive to fire: The Lopez cousins’ war)

It isn’t a matter of standard compliance, but of timing: the roughly two-month gap between the announcement of a P75-billion deal and the later disclosure of a material “poison pill” provision with potential multibillion-peso consequences. This is not something to scoff at. Rules of disclosure are meant to ensure that investors are playing on the same information at the same time. A clause that can impact valuation and control surfaces weeks later—and then the issue no longer resides with the administrative delay but with information asymmetry.

The Philippine Stock Exchange has reacted as expected—issuing a show-cause directive, rather than an instant penalty, which indicates the delay deserves review. The procedural stage is secondary for investors, though. The essential question is simple: were they given a complete picture when it mattered? If not, even briefly, markets respond by pricing in governance risk, and that discount lingers.

Why it matters

Let’s delve into the issue to understand what I mean. In its original form, the so-called “poison pill,” is an anti-takeover device. It shields stockholders from hostile acquirers attempting to buy a company cheaply by diluting or penalizing the aggressor. The point is to conserve value for the greater number. The trigger is external—an opportunistic bidder.

That’s not what we are looking at here. The First Gen structure, identified in filings and reporting, ties economic consequences not to a hostile acquisition, but to a change in management control during a critical investment period tied to its partnership with port magnate Ricky Razon’s Prime Infrastructure.

Put simply: if management stays, the deal proceeds normally. If management changes, the counterparty acquires economic leverage—reportedly including the option to acquire assets under more favorable terms. This is crucial because once the trigger is internal—a leadership decision—the mechanism ceases to be defensive. It becomes behavioral control written into the contract. 

For whom is the pill?

I approach this from first principles. If a company’s value is genuinely institutional—based on assets, cash flows, and strategy—then leadership should be replaceable without destroying that value. Markets assume this. Boards are elected, and capital is allocated on this premise.

But this structure suggests something else: that value is, at least contractually, dependent on the continued presence of a specific executive, in this case Federico “Piki” Lopez, First Gen’s chair and CEO. If he is removed, billions in value may be impaired—not because the business changed, but because the contract says so. 

That is where the numbers begin to sharpen the analysis. First Gen is not a marginal company. It is one of the Philippines’ largest listed power producers, with revenues historically in the range of P130–P150 billion annually, supported by gas-fired plants and renewable assets. Its capital structure is heavy, as is typical for energy firms, with tens of billions in debt tied to long-gestation infrastructure projects. This is a business where cash flow stability and contractual clarity are everything.

Add on the Prime Infrastructure deal here—reported to be approximately P62 billion for a majority share in key gas assets, followed by a subsequent P75 billion commitment into pumped-storage hydro projects. This isn’t just a small transaction or a side deal. This is major strategic move, involving a multi-decade capital deployment cycle of more than P100 billion. This makes the introduction of a governance-triggered clause that can change economic outcomes a fundamental threat that strikes at the deal’s core value.

The exposure is not purely theoretical. Institutional investors are already mapping it out. The Social Security System (SSS) and Government Service Insurance Service (GSIS) both hold approximately P1 billion investments in First Gen. KKR, a global private equity firm, has estimated exposure at P112 billion, with downside potential on the order of P3 billion or about 25% impairment if adverse triggers are activated. 

I hesitate here because this is where common sense needs to kick in.

If a change in leadership—something that boards are supposed to appraise for the purposes of ordinary governance—can cause a P3 billion loss for one investor, with a substantial impairment across pension funds, then the cost of exercising governance can no longer be dismissed as merely procedural. It becomes financially punitive. 

Punitive governance destroys functionality. For non-finance readers, the clause is akin to a gifted, embedded option bestowed upon the counterparty. It has no value until a management change triggers the option—allowing entry into assets under more favorable terms. 

Protection to one

Options are priced in capital markets. They are negotiated. They are paid for. Here, the cost seems to be borne by current shareholders—quietly, conditionally, and only when governance shifts. That is a transfer of value triggered by internal decision-making, not external market forces.

This is where I begin to question intent—not as an accusation, but as a matter of structure. A fair defensive mechanism protects the company, regardless of who sits on the executive chair. This one appears to protect the continuity of the chair itself. The benefits are concentrated: stability for incumbent management. 

The costs are dispersed across pension funds, minority shareholders, and foreign investors who bear the financial fallout even though they have no role in the internal wackamole. That imbalance is glaring and hard to ignore. To be clear, there are legitimate reasons to include change-of-control protections in large infrastructure deals. 

Counterparties want certainty. Projects with long gestation periods—like liquefied  natural gas (LNG) and pumped storage—require stable leadership and execution continuity to mitigate risk. For lenders and partners, pricing this risk is standard. What is unusual is the way those protections are structured—penalizing the mere act of replacing management itself, rather than addressing actual operational disruption or credit deterioration caused by the change. 

That is a narrower trigger: Whose interest is being protected? The response of the market gives an early clue. Valuations adjust as governance uncertainty rises. Investors apply discounts—not out of emotion, but out of risk calibration. A company that introduces conditional value destruction tied to internal leadership outcomes invites three immediate penalties: a governance discount, a transparency discount, and a control risk premium. 

Risk to institutional investors

These consequences are not abstract. They manifest as share price pressure, reduced institutional participation, and a higher cost of capital. The situation is intensified due to the nature of the investors involved. SSS and GSIS are not speculative funds. They represent the retirement savings of millions of Filipinos. When corporate structures emerge that can impair billions in value due to governance triggers, the issue transcends mere corporate design. It becomes a critical concern for everyone.

Let me reiterate my earlier question: Who ultimately shoulders the risk here? Certainly, it is not the executive whose position seems insulated in terms of economics. It is not any counterparty who gains optionality. Instead, the burden falls on the shareholders, many of whom had no inkling in the whole exercise until the issue surfaced. 

Despite the legal complexities, the conclusion is straightforward. This is less a traditional poison pill and more a governance-linked financial mechanism designed to secure a specific individual’s position. By favoring leadership continuity over leadership accountability, this protective mechanism is morphing into a preservation tool—only for Piki. – Rappler.com

Click here for more Vantage Point articles.